The authors have disclosed that they have no financial interests, arrangements, affiliations, or commercial interests with the manufacturers of any products discussed in this article or their competitors.
Cancer Facts and Figures 2014. American cancer Society Web site. Available at: http://www.cancer.org/research/cancerfactsstatistics/cancerfactsfigures2014/. Accessed June 20 2014.
HorwitzLPartovianCLinZ. Hospital-wide (all-condition) 30-day risk standardization readmission measure. Available at: http://www4a.cms.gov/Medicare/Quality-Initiatives-Patient-Assessment-Instruments/MMS/downloads/MMSHospital-WideAll-ConditionReadmissionRate.pdf. Accessed July 25 2013.
SilversteinMDQinHMercerSQ. Risk factors for 30-day hospital readmission in patients ≥ 65 years of age. Proc (Bayl Univ Med Cent)2008;21:363–372.
OduyeboILehmannCUPollackCE. Association of self-reported hospital discharge handoffs with 30-day readmissions. JAMA Intern Med2013;173:624–629.
KrzyzanowskaMKTreacyJMaloneyB. Development of a patient registry to evaluate hospital admissions related to chemotherapy toxicity in a community cancer center. J Oncol Pract2005;1:15–19.
LymanGHKudererNMCrawfordJ. Predicting individual risk of neutropenic complications in patients receiving cancer chemotherapy. Cancer2011;117:1917–1927.
CrawfordJWolffDCulakovaEfor the ANC Study Group. First-cycle risk of severe and febrile neutropenia in cancer patients receiving systemic chemotherapy: results from a prospective nationwide study [abstract]. Poster presented at the 46th Annual ASH Meeting; December4–72004; San Diego, California. Abstract 2210.